Diethyl 2-(methylthio)pyrimidine-4,5-dicarboxylate, 95.0%, 250mg

[(5-ethyl-1,3,4-thiadiazol-2-yl)methyl]amine dihydrochloride, 95.0%, 250mg

5-(5-bromopyridin-3-yl)-1,3,4-oxadiazol-2-amine, 95.0%, 250mg

1-BOC-4-(5-AMINOPYRIDIN-2-YL)-1,4-DIAZEPANE, 97.0%, 1g

3-Mercapto-3-methylbutyl formate, 95.0%, 5g

Viales de muestra, 10 ml, 100 Unidad(es)

Patrón de conductividad ROTI®Calipure, 100000 µS/cm (25 °C), 500 ml, envase de plástico.

ethyl 5-[(2-fluorophenyl)methyl]-1H-pyrazole-4-carboxylate, 95.0%, 1g

Éster metílico del ácido acético, mínimo 99 %, para síntesis, 1 l, envase de vidrio

2-(2-Chlorophenyl)-5,7-dihydroxy-8-((3S,4R)-3-hydroxy-1-methylpiperidin-4-yl)-4H-chromen-4-one hydrochloride, 98%, 5mg

(4R)-8-Methyl-3,4-dihydro-2H-1-benzopyran-4-amine hcl, 97%, 100mg

4-Chloro-2-fluoro-2'-morpholinomethyl benzophenone, 97.0%, 1g

2-(Methylamino)benzonitrile, 95.0%, 25g